Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Bristol Myers Squibb’s Opdualag fails to meet primary endpoint in Phase 3 trial Bristol Myers Squibb has announced that its Phase 3 RELATIVITY-098 clinical trial, designed to evaluate Opdualag (nivolumab and… byPallavi MadhirajuFebruary 14, 2025